Delays in Therapy Associated With Current Prior Authorization Process for the Treatment of Inflammatory Bowel Disease.
Sign Up to like & getrecommendations! Published in 2023 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izad012
Abstract: Despite a high approval rate, there were unnecessary delays in therapy due to prior authorizations. This study identified the impact of type of IBD, FDA-labeled indication, and dose escalations on approvals. read more here.
Keywords: therapy associated; delays therapy; inflammatory bowel; current prior ... See more keywords